At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Adjunctive Anti-Obesity Pharmacotherapy in Adolescents and Young Adults After Bariatric Surgery: A Randomized Controlled Pilot Study
In Brief
A Phase 2 clinical trial evaluating Phentermine, Immediate Release Topiramate, and 2 other interventions for Obesity, Morbid and 4 related conditions. Completed, enrolled 13 participants across 1 site.
Detailed Summary
The goal of this pilot study is to establish the feasibility and initial efficacy of the combination of phentermine and topiramate for adolescents and young adults who require additional risk reduction after bariatric surgery. This study will use a randomized, placebo-controlled, double-blinded design to evaluate an adjunctive 12-week intervention of phentermine + topiramate + standard of care vs. placebos + standard of care 6 months after bariatric surgery, among 12 to 24 year olds who don't achieve expected weight loss or who remain severely obese (n=10 total).
Study Details
Timeline
Interventions
Phentermine tablet
Topiramate tablet
Compounded tablet to mimic phentermine 8mg tablet
Compounded tablet to mimic immediate release topiramate 25mg tablet